Industrial Biotechnology Companies Receive Green Chemistry Awards
News Jun 19, 2012
“Industrial biotechnology is already being used to produce products for the home that are cleaner and safer for the environment, require less energy for manufacturing and lower production costs,” said Brent Erickson, executive vice president of BIO’s Industrial & Environmental Section. “BIO congratulates our members who have been recognized through the Presidential Green Chemistry Awards for their pioneering advances in applying industrial biotechnology to manufacturing. Their achievements show that more widespread adoption of industrial biotechnology processes can help establish a new path for sustainable economic growth and job creation, without continued reliance on foreign oil.”
Elevance Renewable Sciences, Inc. received a Small Business Award for producing high-performing, renewable specialty chemicals at advantageous costs. Elevance employs Nobel-prize-winning catalyst technology to produce novel, high-performance renewable specialty chemicals for many uses that combine the benefits of both petrochemicals and biobased chemicals. The technology consumes significantly less energy and reduces greenhouse gas emissions by 50 percent compared to petrochemical technologies.
Codexis, Inc. received a Greener Synthetic Pathways Award for an efficient biocatalytic process to manufacture simvastatin, a leading drug for treating high cholesterol. The previous multistep method for producing simvastatin was wasteful and used large amounts of hazardous reagents. Codexis optimized the chemical process to greatly reduce hazard and waste, be more cost-effective and meet the needs of customers.
U.S. Study of Dapivirine Ring in Lactating Women Finds Little Drug Gets Into Breast MilkNews
The antiretroviral drug dapivirine that is released from an experimental vaginal ring to protect against HIV is absorbed in very low concentrations into breastmilk.READ MORE
Cell Recycling System Offers Therapeutic Entry Point for Rare Disease TreatmentNews
Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).READ MORE
Cancer Cells Force Normal Cells to Act Like Viruses, Helping Tumors SpreadNews
Researchers reveal how cancer cells force normal cells to act like viruses – allowing tumors to grow, resist treatment, and spread.READ MORE
Comments | 0 ADD COMMENT
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Target Engagement in Biology and Drug Discovery
Feb 19 - Feb 23, 2018